일동제약 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 조노제, was filed 03 Apr 2026.
일동제약: what insiders have been doing
일동제약, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 2 November 2026, brought 3 filings signed by 3 insiders.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €2,165) and 1 sale (1 insider). No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 board member among the declarants. One trade stands out by size: a purchase of €2,165 from 조노제, disclosed on 3 April 2026, or 0.0008% of market capitalisation.
The last purchase on record was published on 3 April 2026, which is 221 days ago.
Compared with its exchange (2,655 companies, median 7 filings), a count of 3 filings is below the norm. Since 2021, the database holds 24 purchases and 4 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -53.1%Entry ₩26,850 · Close 30 Oct 2026 ₩12,580
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 130 shares@ ₩28,961.53850.0008% mcap100.0% of flowShareKRXDART:20260403003255Canonical exit: 29 Jun 2026 (T+90)
- ●Executives0DART
- 2,000 sharesKRXDART:20260220002557
- 2,596 sharesKRXDART:20250708000347
- 521 sharesShareKRXDART:20250703000066Canonical exit: 29 Sept 2025 (T+90)
- 2,000 sharesShareKRXDART:20241224000132Canonical exit: 24 Mar 2025 (T+90)
- 976 sharesKRXDART:20240926000372
- 2,498,660 sharesKRXDART:20240812000666
- 2,249,373 sharesKRXDART:20240805000389Canonical exit: 27 Oct 2024 (T+90)
- ●Executives0DART
- 2,249,373 sharesKRXDART:20231109000396Canonical exit: 6 Feb 2024 (T+90)
- 2,249,373 sharesKRXDART:20230803000452Canonical exit: 18 Oct 2023 (T+90)
- 2,249,373 sharesKRXDART:20230706000433Canonical exit: 1 Oct 2022 (T+90)
- 2,249,373 sharesKRXDART:20230323001484Canonical exit: 21 Jun 2023 (T+90)
- 2,249,373 sharesKRXDART:20220804000302Canonical exit: 2 Nov 2022 (T+90)
- 2,249,373 sharesKRXDART:20220520000449Canonical exit: 18 Aug 2022 (T+90)
- 2,249,373 sharesKRXDART:20220429000951Canonical exit: 28 Jul 2022 (T+90)
- ShareKRXDART:20220407002378Canonical exit: 6 Jul 2022 (T+90)
- 2,249,373 sharesKRXDART:20220325001212Canonical exit: 23 Jun 2022 (T+90)
- 2,249,373 sharesKRXDART:20220322000546Canonical exit: 20 Jun 2022 (T+90)
- ShareKRXDART:20220304000594Canonical exit: 2 Jun 2022 (T+90)
- 2,249,373 sharesKRXDART:20220304000570Canonical exit: 2 Jun 2022 (T+90)
- ShareKRXDART:20220228006184Canonical exit: 29 May 2022 (T+90)
- 2,249,373 sharesKRXDART:20220228006081Canonical exit: 29 May 2022 (T+90)
- 2,249,373 sharesKRXDART:20220222001079Canonical exit: 23 May 2022 (T+90)
25 of 30 declarations
About 일동제약
Il Dong Pharmaceutical is a South Korean pharmaceutical company focused on the development and marketing of medications. It is listed on the XKRX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
